News

Their own mini-boom of recent years has been largely fueled by one firm, Ozempic maker Novo Nordisk A/S, whose diabetes and ...
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...
Greenland is working on strengthening its relations with Denmark following disrespectful rhetoric from the U.S.
Todd Engel, a Maryland man, is suing Ozempic maker Novo Nordisk after allegedly going blind due to the drug, raising concerns ...
An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.
A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...
Drugs such as Ozempic cut our craving for food. But they can’t control our hunger for all the good things in life.
BBC announces 2025 Proms lineup – including first female-fronted Last Night ...
But recent weak U.S. prescription data is leading some investors and analysts to question whether that stellar run, which ...
Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has been struggling during the past year. Its financial results - ...
Denmark and Japan to develop floating wind turbines, police warning over scam tickets, new Danish-made online infobot and ...